Shalby Limited (NSE:SHALBY)
169.29
+0.48 (0.28%)
Jun 1, 2026, 3:29 PM IST
Shalby Revenue
In the fiscal year ending March 31, 2026, Shalby had annual revenue of 11.41B INR with 5.01% growth. Shalby had revenue of 2.87B in the quarter ending March 31, 2026, with 8.51% growth.
Revenue
11.41B
Revenue Growth
+5.01%
P/S Ratio
1.59
Revenue / Employee
4.40M
Employees
2,592
Market Cap
18.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 11.41B | 544.75M | 5.01% |
| Mar 31, 2025 | 10.87B | 1.53B | 16.41% |
| Mar 31, 2024 | 9.34B | 1.29B | 16.00% |
| Mar 31, 2023 | 8.05B | 1.06B | 15.16% |
| Mar 31, 2022 | 6.99B | 2.68B | 62.21% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HealthCare Global Enterprises | 25.45B |
| Rainbow Children's Medicare | 17.03B |
| Park Medi World | 16.79B |
| Jupiter Life Line Hospitals | 15.00B |
| Indraprastha Medical Corporation | 14.83B |
| Yatharth Hospital & Trauma Care Services | 12.33B |
| Artemis Medicare Services | 11.11B |
| Jeena Sikho Lifecare | 7.25B |
Shalby News
- 3 months ago - Shalby inaugurates oncology department with advanced radiotherapy in Surat hospital - Business Upturn
- 10 months ago - Shalby signs MoU with Bhartiya Skill Development University to launch B.Voc programs in healthcare - Business Upturn
- 10 months ago - Shalby shares drop over 2% as Q1 net profit falls 43% YoY to Rs 8.9 crore, Ebitda down 8% YoY - Business Upturn
- 1 year ago - Shalby shares drop 4% as EBITDA falls 20.1% YoY in Q3 - Business Upturn
- 1 year ago - Shalby shares jump 3% after FDA approval for Duraniom knee replacement device - Business Upturn